SCP2 sterol-binding domain-containing protein 1 is a poorly characterized intracellular lipid carrier protein containing a sterol carrier protein 2 (SCP2) domain. The protein is predicted to function as a non-specific lipid transfer protein that binds lipids in a large hydrophobic cavity. Falcon deep research provides the strongest direct biochemical clue to date: a 2024 system-wide analysis of human lipid transfer proteins (Titeca et al.) mapped SCP2D1 ligand-class associations to fatty acids and several lysophospholipid/glycerophospholipid classes (LPC, LPE, LPG, PE, PG/BMP), suggesting a multi-class lipid-binding profile broader than sterol-only. A 2009 targeted siRNA screen (Bartz et al.) found that knockdown of C20orf79/SCP2D1 increased cellular cholesterol staining and LDL uptake, implicating it in cholesterol/LDL handling, though mechanism and effect sizes were not resolved. Unlike its paralog SCP2 which localizes to peroxisomes, SCP2D1 lacks a peroxisomal targeting sequence and is predicted (IBA/phylogenetic inference) to function in the cytosol; however, no SCP2D1-specific localization experiments exist, so localization is underdetermined by direct evidence. Expression is enriched in testis, but SCP2D1 also behaves as a cancer-testis gene, being aberrantly expressed in colon cancer (~35% of patients) and leukemia and inducible by epigenetic (DNMT/HDAC) inhibitors; these are non-core expression observations rather than evidence of molecular function. No direct experimental characterization of purified SCP2D1 (binding constants, transfer rates, enzymatic activity) exists, and no enzymatic or transporter activity has been demonstrated; functional annotations remain largely inferred from domain homology to the well-studied SCP2 protein and from a small number of high-throughput screens.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0005829 cytosol | IBA GO_REF:0000033 | ACCEPT | Summary: Phylogenetic inference predicts SCP2D1 localizes to cytosol. Consistent with lack of peroxisomal targeting sequence and predictions from subcellular localization tools. Unlike paralog SCP2 which has peroxisomal localization, SCP2D1 is predicted to function exclusively in the cytoplasmic compartment. Falcon deep research adds an important caveat: there are NO SCP2D1-specific experiments (endogenous immunofluorescence, fractionation, or proximity labeling) that establish localization, so the compartment is "underdetermined" from direct evidence. The cytosol call rests on phylogenetic inference (IBA) and absence of targeting signals, not on direct SCP2D1 data. Falcon also stresses that peroxisomal targeting features of the paralog SCP2/SCPX cannot be transferred to SCP2D1, which is consistent with the IBA-based cytosolic (rather than peroxisomal) assignment here. Reason: Appropriate cellular compartment annotation supported by phylogenetic inference, domain analysis, and absence of targeting sequences for other organelles. Retained as ACCEPT because falcon does not contradict cytosolic localization; it only notes the absence of direct SCP2D1 localization data, which is already reflected by the IBA evidence code. Supporting Evidence: UniProt:Q9UJQ7 GO; GO:0005829; C:cytosol; IBA:GO_Central. file:human/SCP2D1/SCP2D1-deep-research-perplexity-lite.md SCP2D1 is primarily localized in the **cytoplasm** file:human/SCP2D1/SCP2D1-deep-research-falcon.md No retrieved SCP2D1-specific experiments provided definitive localization (e.g., immunofluorescence of endogenous SCP2D1, organelle fractionation, proximity labeling, or tagged SCP2D1 localization). Therefore, SCP2D1 localization remains **underdetermined** from this evidence set. file:human/SCP2D1/SCP2D1-deep-research-falcon.md these data apply to **SCP2**, not SCP2D1, and cannot be transferred as direct annotation for SCP2D1 |
| GO:0008289 lipid binding | IEA | NEW | Summary: SCP2D1 contains an SCP2 sterol-binding domain predicted to bind lipids. Falcon deep research provides the strongest direct biochemical handle to date: a 2024 system-wide analysis of human lipid transfer proteins (Titeca et al., bioRxiv) included SCP2D1 among LTPs with no previously known ligands and assigned multiple lipid-class associations (fatty acids, lysophosphatidylcholine, lysophosphatidylethanolamine, lysophosphatidylglycerol, phosphatidylethanolamine, and phosphatidylglycerol/BMP). This broadens the likely binding profile beyond "sterol-only" to a multi-class lipid-binding protein, while the GO term lipid binding (GO:0008289) remains the appropriate general molecular function. Note this evidence is preprint-stage and figure-based, with no SCP2D1-specific binding constants or transfer rates extractable; the activity is best treated as lipid binding rather than a demonstrated lipid-transfer or enzymatic activity (falcon found no evidence for catalysis or transporter activity). Reason: Domain homology indicates lipid-binding activity, consistent with SCP2 family sterol carrier function, and falcon deep research adds experimental-screen support (a 2024 LTP ligand-mapping study) for SCP2D1 binding fatty acids and several glycerophospholipids/lysophospholipids. The general term lipid binding (GO:0008289) is retained as it accommodates the multi-class profile; a more specific sterol-only term is not warranted given the broader ligand set reported. Supporting Evidence: file:human/SCP2D1/SCP2D1-deep-research-openai.md the SCP2D1 protein consists largely of a **sterol carrier protein type 2 (SCP2) sterol-binding domain**, a conserved module known for binding lipids. file:human/SCP2D1/SCP2D1-deep-research-falcon.md it is treated as an LTP candidate in recent systematic LTP analyses file:human/SCP2D1/SCP2D1-deep-research-falcon.md SCP2D1 likely participates in **cellular lipid mobilization** involving lysophospholipids and glycerophospholipids and may also bind free fatty acids, suggesting a role broader than “sterol-only” binding file:human/SCP2D1/SCP2D1-deep-research-falcon.md SCP2D1 most plausibly functions as a **lipid-binding protein** with multi-class ligand specificity file:human/SCP2D1/SCP2D1-deep-research-falcon.md No retrieved source demonstrated SCP2D1 catalyzing a biochemical reaction (enzyme activity) or acting as a membrane transporter with defined substrate translocation kinetics. |
Loading supporting content…
Download this section (compressed HTML)Q: What is the specific lipid substrate preference of SCP2D1 and does it differ from the paralog SCP2?
Suggested experts: Lipid biochemists, Structural biologists
Q: What is the role of SCP2D1 in testicular function - spermatogenesis, steroidogenesis, or both?
Suggested experts: Reproductive biologists, Male fertility researchers
Q: Why is SCP2D1 expression so highly restricted to testis, and what regulatory mechanisms control this tissue-specific expression?
Suggested experts: Gene regulation specialists, Developmental biologists
Experiment: Recombinant protein expression and lipid-binding assays to determine substrate specificity (cholesterol vs fatty acids vs acyl-CoA)
Hypothesis: SCP2D1 binds multiple lipid classes with preference for cholesterol
Type: biochemical assay
Experiment: CRISPR knockout of Scp2d1 in mice and phenotypic analysis of testis histology, sperm parameters, and testosterone levels
Hypothesis: SCP2D1 is required for normal spermatogenesis or testicular steroid biosynthesis
Type: genetic manipulation
Experiment: Immunofluorescence microscopy of testis tissue to localize SCP2D1 to specific cell types (germ cells vs Leydig cells vs Sertoli cells)
Hypothesis: SCP2D1 localizes to steroidogenic Leydig cells or to developing germ cells
Type: microscopy
Experiment: Co-immunoprecipitation and mass spectrometry to identify protein interaction partners in testis lysates
Hypothesis: SCP2D1 interacts with steroidogenic enzymes or lipid metabolism proteins predicted by STRING
Type: proteomics
What is not known — curated, literature-grounded statements of the open unknowns (the inverse of core functions).
Gap: SCP2D1's exact lipid-binding and transfer biochemistry remains unresolved. Current evidence supports multi-class lipid binding, but binding constants, transfer rates, lipid preferences, membrane-donor/ acceptor requirements, and whether SCP2D1 functions as a transfer protein versus a lipid sensor or buffer are unknown.
OPEN BIOLOGYONTOLOGY RESIDUAL_SUBGAP
What is known: The review accepts broad lipid binding (GO:0008289) based on SCP2-domain homology and recent ligand- class mapping that includes fatty acids and several lysophospholipid/glycerophospholipid classes. The gap is not whether SCP2D1 plausibly binds lipids, but the quantitative specificity and mechanism needed to define a more precise molecular function.
Significance: Without biochemical specificity, SCP2D1 cannot be curated beyond a broad lipid-binding term, and the relationship between sterol-domain homology, fatty-acid/phospholipid associations, and cholesterol phenotypes remains mechanistically ambiguous.
What would resolve it: Purify recombinant SCP2D1 and measure lipid binding and transfer using defined sterol, fatty-acid, lysophospholipid, phospholipid, and acyl-CoA panels; combine kinetics with structural mapping of the hydrophobic cavity and lipidomics after cellular perturbation.
Provenance (the field's own admissions):
Gap: SCP2D1's direct subcellular localization and site of lipid action remain underdetermined. Cytosolic localization is currently inferred, while peroxisomal localization from SCP2/SCPX cannot be transferred to SCP2D1 and no endogenous SCP2D1 localization experiment has resolved where it acts.
OPEN BIOLOGYCURATION CC_DARK
What is known: SCP2D1 is annotated to the cytosol by IBA/phylogenetic inference and lacks clear peroxisomal targeting evidence. The open issue is whether it acts diffusely in cytosol, at endomembranes, near lipid droplets, mitochondria, testis-specific membranes, or other lipid-trafficking interfaces.
Significance: Localization is essential for interpreting lipid-transfer partners, cholesterol/LDL phenotypes, and whether any SCP2-paralog or pathway annotation can be safely propagated to SCP2D1.
What would resolve it: Use validated endogenous antibodies or epitope knock-in tags for immunofluorescence, organelle fractionation, proximity labeling, and lipid-droplet/endomembrane colocalization in testis-relevant and cholesterol-perturbation models.
Provenance (the field's own admissions):
Gap: The cellular and physiological pathway for SCP2D1 remains unknown: siRNA knockdown alters cholesterol staining and LDL uptake, and expression is enriched in testis and reactivated in some cancers, but it is unresolved whether these observations reflect one lipid-trafficking function, a testis-specific reproductive role, a cancer-testis biomarker state, or separate context-dependent effects.
OPEN BIOLOGY BP_DARK
What is known: Existing evidence connects SCP2D1 to lipid/cholesterol handling phenotypes and to testis/cancer-testis expression patterns. It does not establish the relevant cell type, pathway step, protein partners, or whether SCP2D1 is required for spermatogenesis, steroidogenesis, LDL receptor trafficking, endosomal cholesterol egress, or tumor biology.
Significance: This is the main biological-process gap: a broad lipid-binding MF is plausible, but the organismal and cellular process that needs SCP2D1 is still undefined.
What would resolve it: Combine SCP2D1 knockout/knockdown with filipin/LDL uptake assays, lipidomics, rescue by lipid-binding mutants, and testis-focused models assessing germ-cell, Sertoli-cell, Leydig-cell, steroidogenesis, and sperm phenotypes.
Provenance (the field's own admissions):
Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)